Inspire Medical Systems Announces Preliminary Q2 Revenue Of $195.9M Vs $186.3M Est
Portfolio Pulse from Benzinga Newsdesk
Inspire Medical Systems announced preliminary Q2 revenue of $195.9 million, surpassing the estimated $186.3 million. This represents a 30% increase over the same quarter of 2023, with U.S. revenue at $187.8 million and international revenue at $8.1 million.
July 29, 2024 | 10:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems reported preliminary Q2 revenue of $195.9 million, exceeding the estimated $186.3 million. This represents a 30% increase over the same quarter of 2023, indicating strong growth.
The preliminary Q2 revenue of $195.9 million surpasses the estimated $186.3 million, indicating strong performance and growth. This positive financial result is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100